JP2024535925A5 - - Google Patents
Info
- Publication number
- JP2024535925A5 JP2024535925A5 JP2024519345A JP2024519345A JP2024535925A5 JP 2024535925 A5 JP2024535925 A5 JP 2024535925A5 JP 2024519345 A JP2024519345 A JP 2024519345A JP 2024519345 A JP2024519345 A JP 2024519345A JP 2024535925 A5 JP2024535925 A5 JP 2024535925A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- domain
- modified
- polypeptide
- acid substitutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163249685P | 2021-09-29 | 2021-09-29 | |
| US63/249,685 | 2021-09-29 | ||
| PCT/CA2022/051445 WO2023050006A1 (en) | 2021-09-29 | 2022-09-29 | Modified interleukin p40 subunit proteins and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535925A JP2024535925A (ja) | 2024-10-02 |
| JP2024535925A5 true JP2024535925A5 (https=) | 2025-09-24 |
Family
ID=85780291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519345A Pending JP2024535925A (ja) | 2021-09-29 | 2022-09-29 | 修飾されたインターロイキンｐ４０サブユニットタンパク質及びその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240228567A1 (https=) |
| EP (1) | EP4408870A4 (https=) |
| JP (1) | JP2024535925A (https=) |
| KR (1) | KR20240068070A (https=) |
| CN (1) | CN118043343A (https=) |
| AU (1) | AU2022355496A1 (https=) |
| CA (1) | CA3232071A1 (https=) |
| MX (1) | MX2024003940A (https=) |
| WO (1) | WO2023050006A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI880235B (zh) | 2017-11-28 | 2025-04-11 | 日商中外製藥股份有限公司 | 可調整配體結合活性的配體結合分子 |
| WO2025136986A2 (en) | 2023-12-18 | 2025-06-26 | Genzyme Corporation | Il-12 loss of potency muteins |
| WO2026020161A1 (en) | 2024-07-19 | 2026-01-22 | Cytomx Therapeutics, Inc. | Activatable il-12 constructs and related compositions and methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019355971B2 (en) * | 2018-10-03 | 2025-05-08 | Xencor, Inc. | IL-12 heterodimeric Fc-fusion proteins |
| JP7773991B2 (ja) * | 2020-03-23 | 2025-11-20 | ザイムワークス ビーシー インコーポレイテッド | マスクされたｉｌ１２融合タンパク質及びその使用方法 |
-
2022
- 2022-09-29 WO PCT/CA2022/051445 patent/WO2023050006A1/en not_active Ceased
- 2022-09-29 AU AU2022355496A patent/AU2022355496A1/en active Pending
- 2022-09-29 EP EP22874023.9A patent/EP4408870A4/en active Pending
- 2022-09-29 CA CA3232071A patent/CA3232071A1/en active Pending
- 2022-09-29 MX MX2024003940A patent/MX2024003940A/es unknown
- 2022-09-29 KR KR1020247014070A patent/KR20240068070A/ko active Pending
- 2022-09-29 JP JP2024519345A patent/JP2024535925A/ja active Pending
- 2022-09-29 CN CN202280063447.6A patent/CN118043343A/zh active Pending
-
2024
- 2024-03-28 US US18/620,572 patent/US20240228567A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024535925A5 (https=) | ||
| JP2021007390A5 (https=) | ||
| Senger et al. | Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin | |
| KR100484084B1 (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| DE69529517T2 (de) | Kreisförmig permutierte liganden und kreisförmig permutierte chimärische molekülen | |
| Kistemaker et al. | Synthesis and macrodomain binding of mono‐ADP‐ribosylated peptides | |
| JP2023544834A5 (https=) | ||
| JP2022115876A5 (https=) | ||
| EP2068906B1 (en) | Antiviral agent against animal viruses | |
| EP0602144B1 (en) | Dna sequences encoding gelonin polypeptide | |
| JPH06237772A (ja) | 免疫抑制剤 | |
| HU208162B (en) | Process for producing new proteins and pharmaceutical compositions comprising same | |
| JP2001507944A (ja) | 悪性細胞に対する、ｏｎｃタンパク質を含む、免疫毒素 | |
| JP2008504012A5 (https=) | ||
| JP2023528204A5 (https=) | ||
| JP2023554379A5 (https=) | ||
| JP2024509241A5 (https=) | ||
| JP2026035742A5 (https=) | ||
| JPH07509609A (ja) | ラスタンパク質活性を阻害するペプチド，その製造及び利用 | |
| JPS6394991A (ja) | 酸性繊維芽細胞成長因子のクロ−ニング及び発現 | |
| WO2015143581A1 (zh) | 靶特异性双突变体融合蛋白质及其制备工艺 | |
| Schröder et al. | Primary structure of the neuronal clathrin‐associated protein auxilin and its expression in bacteria | |
| US11865181B2 (en) | Peptidic materials that traffic efficiently to the cell cytosol and nucleus | |
| JP2005500052A5 (https=) | ||
| JPH08511542A (ja) | コイル状−コイルステムループ鋳型 |